» Articles » PMID: 37221595

Extracellular Vesicles: Emerging Roles, Biomarkers and Therapeutic Strategies in Fibrotic Diseases

Overview
Publisher Biomed Central
Specialty Biotechnology
Date 2023 May 24
PMID 37221595
Authors
Affiliations
Soon will be listed here.
Abstract

Extracellular vesicles (EVs), a cluster of cell-secreted lipid bilayer nanoscale particles, universally exist in body fluids, as well as cell and tissue culture supernatants. Over the past years, increasing attention have been paid to the important role of EVs as effective intercellular communicators in fibrotic diseases. Notably, EV cargos, including proteins, lipids, nucleic acids, and metabolites, are reported to be disease-specific and can even contribute to fibrosis pathology. Thus, EVs are considered as effective biomarkers for disease diagnosis and prognosis. Emerging evidence shows that EVs derived from stem/progenitor cells have great prospects for cell-free therapy in various preclinical models of fibrotic diseases and engineered EVs can improve the targeting and effectiveness of their treatment. In this review, we will focus on the biological functions and mechanisms of EVs in the fibrotic diseases, as well as their potential as novel biomarkers and therapeutic strategies.

Citing Articles

Optimizing therapeutic outcomes: preconditioning strategies for MSC-derived extracellular vesicles.

Song Y, Liang F, Tian W, Rayhill E, Ye L, Tian X Front Pharmacol. 2025; 16:1509418.

PMID: 39995418 PMC: 11847897. DOI: 10.3389/fphar.2025.1509418.


Small Extracellular Vesicles from Breast Cancer Cells Induce Cardiotoxicity.

Osorio-Mendez J, Gomez-Grosso L, Montoya-Ortiz G, Novoa-Herran S, Dominguez-Romero Y Int J Mol Sci. 2025; 26(3).

PMID: 39940718 PMC: 11816698. DOI: 10.3390/ijms26030945.


Bioelectric stimulation outperforms brain derived neurotrophic factor in promoting neuronal maturation.

Diego-Santiago M, Gonzalez M, Zamora Sanchez E, Cortes-Carrillo N, Dotti C, Guix F Sci Rep. 2025; 15(1):4772.

PMID: 39922942 PMC: 11807145. DOI: 10.1038/s41598-025-89330-4.


Noninvasive in vivo imaging of macrophages: understanding tumor microenvironments and delivery of therapeutics.

Gangadaran P, Onkar A, Rajendran R, Goenka A, Oh J, Khan F Biomark Res. 2025; 13(1):20.

PMID: 39865337 PMC: 11770947. DOI: 10.1186/s40364-025-00735-9.


Berberine Mediates Exosomes Regulating the Lipid Metabolism Pathways to Promote Apoptosis of RA-FLS Cells.

Guo S, Wang Z, Xie D, Cai Y, Wang Y, Wang X Pharmaceuticals (Basel). 2024; 17(11).

PMID: 39598419 PMC: 11597526. DOI: 10.3390/ph17111509.


References
1.
Chen L, Yang Y, Yue R, Peng X, Yu H, Huang X . Exosomes derived from hypoxia-induced alveolar epithelial cells stimulate interstitial pulmonary fibrosis through a HOTAIRM1-dependent mechanism. Lab Invest. 2022; 102(9):935-944. DOI: 10.1038/s41374-022-00782-y. View

2.
Perelas A, Silver R, Arrossi A, Highland K . Systemic sclerosis-associated interstitial lung disease. Lancet Respir Med. 2020; 8(3):304-320. DOI: 10.1016/S2213-2600(19)30480-1. View

3.
Kim S, Lee S, Lim J, Choi H, Kang H, Jeon N . Human bone marrow-derived mesenchymal stem cells play a role as a vascular pericyte in the reconstruction of human BBB on the angiogenesis microfluidic chip. Biomaterials. 2021; 279:121210. DOI: 10.1016/j.biomaterials.2021.121210. View

4.
Eguchi A, Yan R, Pan S, Wu R, Kim J, Chen Y . Comprehensive characterization of hepatocyte-derived extracellular vesicles identifies direct miRNA-based regulation of hepatic stellate cells and DAMP-based hepatic macrophage IL-1β and IL-17 upregulation in alcoholic hepatitis mice. J Mol Med (Berl). 2020; 98(7):1021-1034. PMC: 7810220. DOI: 10.1007/s00109-020-01926-7. View

5.
Shichino S, Abe J, Ueha S, Otsuji M, Tsukui T, Kosugi-Kanaya M . Reduced supply of monocyte-derived macrophages leads to a transition from nodular to diffuse lesions and tissue cell activation in silica-induced pulmonary fibrosis in mice. Am J Pathol. 2015; 185(11):2923-38. DOI: 10.1016/j.ajpath.2015.07.013. View